Arcus Capital Partners’s JP Morgan Alerian MLP Index ETN 5/24/24 AMJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37
Closed -$802 372
2022
Q4
$802 Buy
+37
New +$812 ﹤0.01% 343
2017
Q4
Sell
-17,850
Closed -$504K 121
2017
Q3
$504K Sell
17,850
-25,213
-59% -$725K 0.26% 66
2017
Q2
$1.28M Sell
43,063
-10,736
-20% -$330K 0.81% 21
2017
Q1
$1.74M Buy
53,799
+711
+1% +$23.2K 1.1% 13
2016
Q4
$1.68M Buy
53,088
+815
+2% +$24.9K 1.13% 11
2016
Q3
$1.65M Sell
52,273
-10,963
-17% -$345K 1.2% 11
2016
Q2
$2.01M Sell
63,236
-1,444
-2% -$43K 1.93% 8
2016
Q1
$1.75M Sell
64,680
-55
-0.1% -$1.39K 1.25% 10
2015
Q4
$1.88M Buy
+64,735
New +$1.99M 1.35% 11

Other funds holding AMJ

Arcus Capital Partners's AMJ Position: Q1 2023 in Review

Arcus Capital Partners sold out of JP Morgan Alerian MLP Index ETN 5/24/24 (AMJ) in Q1 2023, closing a stake of 37 shares — an estimated $802 sold.

Arcus Capital Partners first reported a position in AMJ in Q4 2015 and held it in 9 quarters. The position peaked at $2.01M in Q2 2016. 173 funds tracked by Wall St. Rank hold AMJ as of Q1 2023.

  • Arcus Capital Partners reported no remaining JP Morgan Alerian MLP Index ETN 5/24/24 position as of Q1 2023 after selling out during the quarter.
  • Arcus Capital Partners sold 37 JP Morgan Alerian MLP Index ETN 5/24/24 shares in Q1 2023, an estimated $802.
  • Arcus Capital Partners first reported a position in JP Morgan Alerian MLP Index ETN 5/24/24 in Q4 2015 and held it in 9 quarters.
  • Arcus Capital Partners's JP Morgan Alerian MLP Index ETN 5/24/24 position peaked at $2.01M in Q2 2016.
  • 173 funds tracked by Wall St. Rank held JP Morgan Alerian MLP Index ETN 5/24/24 as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.